company background image
ME

23andMe Holding NasdaqGS:ME Stock Report

Last Price

US$3.05

Market Cap

US$1.4b

7D

4.5%

1Y

-59.5%

Updated

01 Dec, 2022

Data

Company Financials +
ME fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ME Stock Overview

23andMe Holding Co. operates as a consumer genetics testing company.

23andMe Holding Co. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for 23andMe Holding
Historical stock prices
Current Share PriceUS$3.05
52 Week HighUS$8.86
52 Week LowUS$2.12
Beta1.24
1 Month Change-2.87%
3 Month Change-7.58%
1 Year Change-59.55%
3 Year Changen/a
5 Year Changen/a
Change since IPO-68.88%

Recent News & Updates

Recent updates

23andMe Holding Co. (NASDAQ:ME) Just Reported, And Analysts Assigned A US$5.00 Price Target

Aug 11
23andMe Holding Co. (NASDAQ:ME) Just Reported, And Analysts Assigned A US$5.00 Price Target

Need To Know: Analysts Are Much More Bullish On 23andMe Holding Co. (NASDAQ:ME) Revenues

Feb 18
Need To Know: Analysts Are Much More Bullish On 23andMe Holding Co. (NASDAQ:ME) Revenues

Companies Like 23andMe Holding (NASDAQ:ME) Are In A Position To Invest In Growth

Sep 17
Companies Like 23andMe Holding (NASDAQ:ME) Are In A Position To Invest In Growth

Shareholder Returns

MEUS HealthcareUS Market
7D4.5%3.2%1.5%
1Y-59.5%13.7%-14.8%

Return vs Industry: ME underperformed the US Healthcare industry which returned 9.7% over the past year.

Return vs Market: ME underperformed the US Market which returned -18.9% over the past year.

Price Volatility

Is ME's price volatile compared to industry and market?
ME volatility
ME Average Weekly Movement10.4%
Healthcare Industry Average Movement8.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: ME is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: ME's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006n/aAnne Wojcickihttps://www.23andme.com

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit.

23andMe Holding Co. Fundamentals Summary

How do 23andMe Holding's earnings and revenue compare to its market cap?
ME fundamental statistics
Market CapUS$1.39b
Earnings (TTM)-US$314.54m
Revenue (TTM)US$297.62m

4.7x

P/S Ratio

-4.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ME income statement (TTM)
RevenueUS$297.62m
Cost of RevenueUS$159.54m
Gross ProfitUS$138.08m
Other ExpensesUS$452.62m
Earnings-US$314.54m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.69
Gross Margin46.40%
Net Profit Margin-105.68%
Debt/Equity Ratio0%

How did ME perform over the long term?

See historical performance and comparison